Esperion Therapeutics (ESPR) EPS (Weighted Average and Diluted) Growth (3y) (2021 - 2026)
Esperion Therapeutics (ESPR) EPS (Weighted Average and Diluted) Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 52.55% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 6.07% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 6.19% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -46.43% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 64.08% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -19.39% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -16.96% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -100.00% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 260.88% |
| 10 | Esperion Therapeutics | 49.69 Mn | -118.16 Mn | 45.53 Mn | 49.79% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 49.79% |
| Dec 31, 2025 | 34.49% |
| Sep 30, 2025 | 41.76% |
| Jun 30, 2025 | 61.48% |
| Mar 31, 2025 | 39.11% |
| Dec 31, 2024 | 58.42% |
| Sep 30, 2024 | 61.46% |
| Jun 30, 2024 | 41.75% |
| Mar 31, 2024 | 28.00% |
| Dec 31, 2023 | 49.23% |
| Sep 30, 2023 | 50.60% |
| Jun 30, 2023 | -28.19% |
| Mar 31, 2023 | 34.72% |
| Dec 31, 2022 | 31.76% |
| Jun 30, 2022 | 19.46% |
| Mar 31, 2022 | -32.06% |
| Jun 30, 2021 | 0.79% |
| Mar 31, 2021 | -26.48% |